Weighted Average Number of Shares Outstanding, Basic of Orchard Therapeutics plc from 30 Jun 2021 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Orchard Therapeutics plc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 30 Sep 2023.
  • Orchard Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 228,388,561,000.
  • Orchard Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 127,975,062, a 3.2% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Orchard Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 228,388,561,000* +228,260,428,908 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 189,286,329 +61,431,733 +48% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 141,809,004 +14,114,219 +11% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 127,975,062 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2023 2022 FY
Q3 2022 128,132,092 +755,530 +0.59% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 127,854,596 +1,901,762 +1.5% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 127,694,785 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 127,376,562 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 125,952,834 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2

Orchard Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 127,975,062 +4,011,300 +3.2% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2023 2022 FY
2021 123,963,762 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.